Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
May 20, 2024•1 hr 17 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-positive breast cancers, including strategies for monitoring and managing treatment-related toxicities.
CME information and select publications here.
For the best experience, listen in Metacast app for iOS or Android